微卫星不稳定在结直肠癌的应用及研究进展
摘要
关键词
全文:
PDF参考
Praphulla Chandra S, Krishna KS, Philip AK. P-2 Re-evaluating
the trends in colon cancer[J]. Annals of Oncology,2023(6):5.
Kevin R. Loughlin. William B. Coley[J]. Urologic Clinics of North
America,2020,47(4):413-417.
Chen M, Wang Z, Liu Z, et al. PD-1/PD-L1 Inhibitor Plus
Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite
Instability Gastrointestinal Cancers: A Multicenter Retrospective
Study[J]. JCO Precis Oncol. 2023;7:e2200463.
Zoran Gatalica, Semir Vranic, Gargi D. et al. Thymidylate
Synthase Over-Expression Underlies the Observed Lack of 5-Fu
Therapy Benefit for Msi-H Colorectal Cancers[J]. Annals of
Oncology,2014;25 (0):iv195-iv195.
Klingbiel D, Saridakis Z, Roth AD, et al. Prognosis of stage II and
III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in
relation to microsatellite status: results of the PETACC-3 trial[J].
Ann Oncol 2015,26:126-132.
Guastadisegni C, Colafranceschi M, Ottini L, et al. Microsatellite
instability as a marker of prognosis and response to therapy: a
meta-analysis of colorectal cancer survival data[J]. European
journal of cancer (Oxford, England : 1990), 2010,46(15):2788-
Llosa NJ, Cruise M, Tam A, et al. The vigorous immune
microenvironment of microsatellite instable colon cancer is
balanced by multiple counter-inhibitory checkpoints[J]. Cancer
Discovery,2015,5(1):43-51.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i5.17774
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。